IP Library Granted Patent US 7,173,137
Granted Patent B2
US 7,173,137 · App. 10/732,698 · Granted Feb 6, 2007

Epothilone analogs

Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,173,137
App. No.
10/732,698
Granted
Feb 6, 2007
Kind
B2
Abstract

Epothilone A, epothilone B, analogs of epothilone and libraries of epothilone analogs are synthesized. Epothilone A and B are known anticancers agents that derive their anticancer activity by the prevention of mitosis through the induction and stabilization of microtubulin assembly. The analogs of epothilone are novel. Several of the analogs are demonstrated to have a superior cytotoxic activity as compared to epothilone A or epothilone B as demonstrated by their enhanced ability to induce the polymerization and stabilization of microtubules.

Claims (78)

1. A compound represented by the following structure (formula (I)):

wherein n is 1 to 5; either R* is —OR 1 and R** is hydrogen, or R* and R** together form a further bond so that a double bond is present between the two carbon atoms carrying R* and R**; R 1 is a radical selected from the group consisting of hydrogen or methyl, or a protecting group; R 2 is a radical selected from the group consisting of hydrogen, methylene and methyl; R 3 is a radical selected from the group consisting of hydrogen, methylene and methyl; R 4 is a radical selected from the group consisting of hydrogen or methyl, or is a protecting group; R 5 is a radical selected from the group consisting of hydrogen, methyl, —CHO, —COOH, —CO 2 Me, —CO 2 (tert-butyl), —CO 2 (iso-propyl), —CO 2 (phenyl), —CO 2 (benzyl), —CONH(furfuryl), —CO 2 (N-benzo-(2R,3S)-3-phenylisoserine), —CON(methyl) 2 , —CON (ethyl) 2 , —CONH(benzyl), —CH═CH 2 , HC≡C—, and —CH 2 R 11 ; R 11 is a radical selected from the group consisting of —OH, —O-Trityl, —O—(C 1 –C 6 alkyl), —(C 1 –C 6 alkyl), —O-benzyl, —O-allyl, —O—COCH 3 , —O—COCH 2 Cl, —O—COCH 2 CH 3 , —O—COCF 3 , —O—COCH(CH 3 ) 2 , —O—CO—C(CH 3 ) 3 , —O—CO(cyclopropane), —OCO(cyclohexane), —O—COCH═CH 12 , —O—CO-Phenyl, —O-(2-furoyl), —O-(N-benzo-(2R,3S)-3-phenylisoserine), —O-cinnamoyl, —O-(acetyl-phenyl), —O-(2-thiophenesulfonyl), —S—(C 1 –C 6 alkyl), —SH, —S-Phenyl, —S-Benzyl, —S-furfuryl, —NH 2 , —N 3 , —NHCOCH 3 , —NHCOCH 2 Cl, —NHCOCH 2 CH 3 , —NHCOCF 3 , —NHCOCH(CH 3 ) 2 , —NHCO—C(CH 3 ) 3 , —NHCO(cyclopropane), —NHCO(cyclohexane), —NHCOCH═CH 2 , —NHCO-Phenyl, —NH(2-furoyl), —NH—(N-benzo-(2R,3S)-3-phenylisoserine), —NH-(cinnamoyl), —NH-(acetyl-phenyl), —NH-(2-thiophenesulfonyl), —F, —Cl, I, —CH 2 CO 2 H and methyl; R 6 is absent, methylene, or oxygen; R 8 is a radical selected from the group represented by the formulas:

wherein R 9 is a radical selected from the group consisting of hydrogen and methyl; R 10 is a radical selected from the group represented by the formulas:

wherein R x is acyl;

or a salt thereof where a salt-forming group is present;

where, in the above structures, “a” can be either absent or a single bond; “b” can be either a single or double bond; “c” can be either absent or a single bond; “d” can be either absent or a single bond, and the following provisos pertain:

a. if R 2 is methylene, then R 3 is methylene;

b. if R 2 and R 3 are both methylene, then “a” is a single bond;

c. if R 2 and R 3 are selected from the group consisting of hydrogen and methyl, then the single bond “a” is absent;

d. if n is 3, R 2 is methyl, R 3 is methyl, R 5 is selected from the group consisting of methyl and hydrogen, R 6 is oxygen, R 8 is represented by the formula:

wherein R 9 is hydrogen, and R 10 is represented by the formula

then R 1 and R 4 cannot both be simultaneously hydrogen or methyl or acetyl;

e. if R 6 is oxygen, then “c” and “d” are both a single bond and “b” is a single bond;

f. if R 6 is absent, then “c” and “d” are absent and “b” is a double bond; and

g. if “b” is a double bond then R 6 , “c”, and “d” are absent.

2. A compound of the formula I according to claim 1 , wherein n, a, b, c, d, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 have the meanings given in claim 1 , or a salt thereof where a salt-forming group is present, with the exception of a compound of the formula I

wherein

n is 3;

R 1 is hydrogen, methyl, acetyl, benzoyl, trialkyl silyl or benzyl;

R 2 is methyl;

R 3 is methyl;

R 4 is hydrogen, methyl, acetyl, benzoyl, trialkyl silyl or benzyl;

R 5 is hydrogen or methyl;

R 6 is O or

R 6 is absent and a is a double bond;

R 8 is a radical of the formula

wherein

R 9 is a radical selected from the group consisting of hydrogen and methyl; and

R 10 is a radical represented by the formula:

3. A compound according to claim 1 , represented by formula II,

wherein n is one to five,

R 1 is a radical selected from the group consisting of hydrogen, methyl or a protecting group,

R 4 is a radical selected from the group consisting of hydrogen, methyl or a protecting group,

R 5 is a radical selected from the group consisting of hydrogen, methyl, —CHO, —COOH, CO 2 Me, —CO 2 (tert-butyl), —CO 2 (iso-propyl), —CO 2 (phenyl), —CO 2 (benzyl), —CONH(furfuryl), CO 2 (N-benzo-(2R,3S)-3-phenylisoserine), —CON(methyl) 2 , —CON(ethyl) 2 , —CONH(benzyl, —CH 2 R 11 , —CH═CH 2 and; where R 11 is a radical selected from the group consisting of —OH, —O-Trityl, —O—(C 1 –C 6 alkyl), —O-benzyl, —O-allyl, —O—COCH 3 , —O—COCH 2 Cl, —O—COCH 2 CH 3 , —O—COCF 3 , —O—COCH(CH 3 ) 2 , —O—CO—C(CH 3 ) 3 , —O—CO(cycloprane), —OCO(cyclohexane), —O—COCH═CH 2 , —O—CO-phenyl, —O-(2-furoyl), —O—(N-benzo-(2R,3S)-3-phenylisoserine), —O-cinnamoyl, —O-(acetyl-phenyl), —O-(2-thiophenesulfonyl), —S—(C 1 –C 6 alkyl), —SH, —S-Phenyl, —S-Benzyl, —S-furfuryl, —NH 2 , —N 3 , —NHCOCH 3 , —NHCOCH 2 Cl, —NHCOCH 2 CH 3 , —NHCOCF 3 , —NHCOCH(CH 3 ) 2 , —NHCO—C(CH 3 ) 3 , —NHCO(cyclopropane), —NHCO(cyclohexane), —NHCOCH═CH 2 , —NHCO-phenyl, —NH(2-furoyl), —NH—(N-benzo-(2R,3S)-3-phenylisoserine), —NH-(cinnamoyl), —NH-(acetyl-phenyl), —NH-(2-thiophenesulfonyl), —F, —Cl, I, CH 2 CO 2 ,H, —(C 1 –C 6 alkyl) and methyl;

and R 10 is a radical selected from the group represented by the formulae:

wherein R x is acyl;

with the proviso that if R 5 is either methyl or hydrogen and R 10 is represented by the following formula:

then R 1 and R 4 cannot simultaneously be hydrogen or methyl or acetyl.

4. A compound of the formula II according to claim 3 , wherein the compound has the formula IIa

wherein n is 3 and R 1 , R 4 , R 5 and R 10 are as defined in claim 3 , or a salt thereof where a salt-forming group is present.

5. A compound according to claim 3 of the formula

wherein R 10 is as defined in claim 3 and R 5 is —CH 2 F, —CH 2 Cl, CH 2 OOCCH 3 , —CH 2 CH 3 or —CH═CH 2 .

6. A compound of the formula

wherein R 5 is —CH 2 F, —CH 2 Cl, CH 2 OOCCH3, —CH 2 CH 3 or —CH═CH 2 .

7. A compound according to claim 1 of the formula III,

wherein n preferably is one to five;

R 1 is a radical selected from the group consisting of hydrogen, methyl or a protecting group,

R 4 is a radical selected from the group consisting of hydrogen, methyl or a protecting group,

R 5 is a radical selected from the group consisting of hydrogen, methyl, —CHO, —COOH, CO 2 Me, —CO 2 (tert-butyl), —CO 2 (iso-propyl), —CO 2 (phenyl), —CO 2 (benzyl), —CONH(furfuryl), CO 2 (N-benzo-(2R,3S)-3-phenylisoserine), —CON(methyl) 2 , —CON(ethyl) 2 , —CONH(benzyl), and —CH 2 R 11 ,; or in a broader aspect also from —CH═CH 2 and; where R 11 is a radical selected from the group consisting of —OH, —O-Trityl, —O—(C 1 –C 6 alkyl), —O-benzyl, —O-allyl, —O—COCH 3 , —O—COCH 2 Cl, —O—COCH 2 CH 3 , —O—COCF 3 , —O—COCH(CH 3 ) 2 , —O—CO—C(CH 3 ) 3 , —O—CO(cycloprane), —OCO(cyclohexane), —O—COCH═CH 2 , —O—CO-phenyl, —O-(2-furoyl), —O—(N-benzo-(2R,3S)-3-phenylisoserine), —O-cinnamoyl, —O-(acetyl-phenyl), —O-(2-thiophenesulfonyl), —S—(C 1 –C 6 alkyl), —SH, —S-Phenyl, —S-Benzyl, —S-furfuryl, —NH 2 , —N 3 , —NHCOCH 3 , —NHCOCH 2 Cl, —NHCOCH 2 CH 3 , —NHCOCF 3 , —NHCOCH(CH 3 ) 2 , —NHCO—C(CH 3 ) 3 , —NHCO(cyclopropane), —NHCO(cyclohexane), —NHCOCH═CH 2 , —NHCO-phenyl, —NH(2-furoyl), —NH—(N-benzo-(2R,3S)-3-phenylisoserine), —NH-(cinnamoyl), —NH-(acetyl-phenyl), —NH-(2-thiophenesulfonyl), —F, —Cl, —I, CH 2 CO 2 ,H;

and from —(C 1 –C 6 alkyl) and methyl; and

and R 10 is a radical selected from the group represented by the formulae:

wherein R x is acyl;

with the proviso that if R 5 is either methyl or hydrogen and R 10 is represented by the following formula:

then R 1 and R 4 cannot simultaneously be hydrogen or methyl or acetyl;

or a salt thereof if a salt-froming group is present.

8. A compound of formula III according to claim 7 wherein R 5 is —CH 2 F, —CH 2 Cl, CH 2 OOCCH 3 , —CH 2 CH 3 or —CH═CH 2 the double bond with the wavered line is in cis form and the remaining moieties are as defined in claim 7 .

9. A compound according to claim 1 of the formula IV

wherein R 1 is a radical selected from the group consisting of hydrogen, methyl or a protecting group, R 4 is a radical selected from the group consisting of hydrogen, methyl or a protecting group, R 5 is a radical selected from the group consisting of hydrogen and methyl, R 10 is a radical selected from the group represented by the formulae:

wherein R x is acyl;

R 3 is a radical selected from hydrogen and methyl;

R 2 is hydrogen and methyl; and R 9 is hydrogen or methyl;

with the following provisos that

if R 3 and R 2 are hydrogen or methyl, then the single bond “a” is absent; and if R 5 is methyl or hydrogen and R 10 is represented by the formula

then R 1 and R 4 cannot simultaneously be hydrogen or methyl or acetyl;

or a salt thereof if a salt-froming group is present.

10. A compound according to claim 1 of the formula V

wherein

R 1 is a radical selected from the group consisting of hydrogen, methyl or a protecting group,

R 4 is a radical selected from the group consisting of hydrogen, methyl or a protecting group,

R 5 is a radical selected from the group consisting of hydrogen and methyl,

R 10 is a radical selected from the group represented by the formulae:

wherein R x is acyl;

R 3 is a radical selected from hydrogen, methylene or methyl;

R 2 is hydrogen, methylene or methyl; and R 9 is hydrogen or methyl;

with the following provisos that

if R 3 is methylene, then R 2 is methylene; if R 3 and R 2 are methylene, then R 3 and R 2 are chemically bonded to each other through a single bond “a”; if R 3 and R 2 are hydrogen or methyl, then the single bond “a” is absent; and if R 5 is methyl or hydrogen and R 10 is represented by the formula

then R 1 and R 4 cannot simultaneously be hydrogen or methyl or acetyl.

11. A compound according to claim 5 of the formula.

Assignments (1)
CONFIRMATORY LICENSE Recorded Dec 20, 2017
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044919/0829 →
Continuity (5)
Division 0931988500
Continuation In Part 0892386900 · Sep 4, 1997
Continuation In Part 0885653300 · May 14, 1997
Provisional Application 6003286400 · Dec 13, 1996
Related Publication 20040127432A1 · Jul 1, 2004